Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

A history of atrial fibrillation and outcomes in chronic advanced systolic heart failure: a propensity-matched study.

Ahmed MI, White M, Ekundayo OJ, Love TE, Aban I, Liu B, Aronow WS, Ahmed A.

Eur Heart J. 2009 Aug;30(16):2029-37. doi: 10.1093/eurheartj/ehp222. Epub 2009 Jun 16.

2.

β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure: Association With Mortality in a Nationwide Cohort Study.

Nielsen PB, Larsen TB, Gorst-Rasmussen A, Skjøth F, Lip GY.

Circ Heart Fail. 2016 Feb;9(2):e002597. doi: 10.1161/CIRCHEARTFAILURE.115.002597.

3.

Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.

Gheorghiade M, Fonarow GC, van Veldhuisen DJ, Cleland JG, Butler J, Epstein AE, Patel K, Aban IB, Aronow WS, Anker SD, Ahmed A.

Eur Heart J. 2013 May;34(20):1489-97. doi: 10.1093/eurheartj/eht120. Epub 2013 Apr 16.

4.

Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation.

Kao DP, Davis G, Aleong R, O'Connor CM, Fiuzat M, Carson PE, Anand IS, Plehn JF, Gottlieb SS, Silver MA, Lindenfeld J, Miller AB, White M, Murphy GA, Sauer W, Bristow MR.

Eur J Heart Fail. 2013 Mar;15(3):324-33. doi: 10.1093/eurjhf/hfs181. Epub 2012 Dec 7.

5.

Outcomes in younger and older adults with chronic advanced systolic heart failure: a propensity-matched study.

Ahmed MI, Mujib M, Desai RV, Feller MA, Daniel C, Aban IB, Love TE, Deedwania P, Pitt B, Aronow WS, Ahmed A.

Int J Cardiol. 2012 Jan 26;154(2):128-33. doi: 10.1016/j.ijcard.2010.09.006. Epub 2010 Oct 14.

6.

Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure.

Shah M, Avgil Tsadok M, Jackevicius CA, Essebag V, Behlouli H, Pilote L.

Am J Cardiol. 2014 Aug 1;114(3):401-6. doi: 10.1016/j.amjcard.2014.05.013. Epub 2014 May 16.

PMID:
24950677
7.

Gender-related dissociation in outcomes in chronic heart failure: reduced mortality but similar hospitalization in women.

Ahmed MI, Lainscak M, Mujib M, Love TE, Aban I, Piña IL, Aronow WS, Bittner V, Ahmed A.

Int J Cardiol. 2011 Apr 1;148(1):36-42. doi: 10.1016/j.ijcard.2009.10.019. Epub 2009 Nov 24.

8.

Effect of radiofrequency catheter ablation for atrial fibrillation on morbidity and mortality: a nationwide cohort study and propensity score analysis.

Chang CH, Lin JW, Chiu FC, Caffrey JL, Wu LC, Lai MS.

Circ Arrhythm Electrophysiol. 2014 Feb;7(1):76-82. doi: 10.1161/CIRCEP.113.000597. Epub 2014 Jan 20.

9.

Warfarin use and outcomes in patients with advanced chronic systolic heart failure without atrial fibrillation, prior thromboembolic events, or prosthetic valves.

Mujib M, Rahman AA, Desai RV, Ahmed MI, Feller MA, Aban I, Love TE, White M, Deedwania P, Aronow WS, Fonarow G, Ahmed A.

Am J Cardiol. 2011 Feb 15;107(4):552-7. doi: 10.1016/j.amjcard.2010.10.012. Epub 2010 Dec 22.

10.

Effects of peripheral arterial disease on outcomes in advanced chronic systolic heart failure: a propensity-matched study.

Ahmed MI, Aronow WS, Criqui MH, Aban I, Love TE, Eichhorn EJ, Ahmed A.

Circ Heart Fail. 2010 Jan;3(1):118-24. doi: 10.1161/CIRCHEARTFAILURE.109.866558. Epub 2009 Oct 27.

11.

Beta-blockers and outcome in heart failure and atrial fibrillation: a meta-analysis.

Rienstra M, Damman K, Mulder BA, Van Gelder IC, McMurray JJ, Van Veldhuisen DJ.

JACC Heart Fail. 2013 Feb;1(1):21-8. doi: 10.1016/j.jchf.2012.09.002. Epub 2013 Feb 4. Review.

PMID:
24621795
12.

Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.

O'Meara E, Khairy P, Blanchet MC, de Denus S, Pedersen OD, Levesque S, Talajic M, Ducharme A, White M, Racine N, Rouleau JL, Tardif JC, Roy D; AF-CHF investigators.

Circ Heart Fail. 2012 Sep 1;5(5):586-93. Epub 2012 Jul 12.

13.

Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.

Olsson LG, Swedberg K, Ducharme A, Granger CB, Michelson EL, McMurray JJ, Puu M, Yusuf S, Pfeffer MA; CHARM Investigators.

J Am Coll Cardiol. 2006 May 16;47(10):1997-2004. Epub 2006 Apr 27.

14.

Coronary artery disease, coronary revascularization, and outcomes in chronic advanced systolic heart failure.

Gheorghiade M, Flaherty JD, Fonarow GC, Desai RV, Lee R, McGiffin D, Love TE, Aban I, Eichhorn EJ, Bonow RO, Ahmed A.

Int J Cardiol. 2011 Aug 18;151(1):69-75. doi: 10.1016/j.ijcard.2010.04.092. Epub 2010 Jun 16.

15.

Association between smoking and outcomes in older adults with atrial fibrillation.

Pawar PP, Jones LG, Feller M, Guichard JL, Mujib M, Ahmed MI, Roy B, Rahman T, Aban IB, Love TE, White M, Aronow WS, Fonarow GC, Ahmed A.

Arch Gerontol Geriatr. 2012 Jul-Aug;55(1):85-90. doi: 10.1016/j.archger.2011.05.027. Epub 2011 Jul 6.

16.

Age-dependent prognostic significance of atrial fibrillation in outpatients with chronic heart failure: data from the Italian Network on Congestive Heart Failure Registry.

Baldasseroni S, Orso F, Fabbri G, De Bernardi A, Cirrincione V, Gonzini L, Fumagalli S, Marchionni N, Midi P, Maggioni AP; Italian Network on Congestive Heart Failure Investigators.

Cardiology. 2010;116(2):79-88. doi: 10.1159/000315312. Epub 2010 Jun 2.

PMID:
20516683
17.

QRS duration predicts death and hospitalization among patients with atrial fibrillation irrespective of heart failure: evidence from the AFFIRM study.

Whitbeck MG, Charnigo RJ, Shah J, Morales G, Leung SW, Fornwalt B, Bailey AL, Ziada K, Sorrell VL, Zegarra MM, Thompson J, Hosn NA, Campbell CL, Gurley J, Anaya P, Booth DC, Di Biase L, Natale A, Smyth S, Moliterno DJ, Elayi CS; AFFIRM investigators.

Europace. 2014 Jun;16(6):803-11. doi: 10.1093/europace/eut335. Epub 2013 Dec 23.

18.

Angiotensin receptor blockers and outcomes in real-world older patients with heart failure and preserved ejection fraction: a propensity-matched inception cohort clinical effectiveness study.

Patel K, Fonarow GC, Kitzman DW, Aban IB, Love TE, Allman RM, Gheorghiade M, Ahmed A.

Eur J Heart Fail. 2012 Oct;14(10):1179-88. Epub 2012 Jul 3.

19.

Race and the natural history of chronic heart failure: a propensity-matched study.

Gambassi G, Agha SA, Sui X, Yancy CW, Butler J, Giamouzis G, Love TE, Ahmed A.

J Card Fail. 2008 Jun;14(5):373-8. doi: 10.1016/j.cardfail.2008.02.004. Epub 2008 May 27.

20.

Exercise Training in Patients With Chronic Heart Failure and Atrial Fibrillation.

Luo N, Merrill P, Parikh KS, Whellan DJ, Piña IL, Fiuzat M, Kraus WE, Kitzman DW, Keteyian SJ, O'Connor CM, Mentz RJ.

J Am Coll Cardiol. 2017 Apr 4;69(13):1683-1691. doi: 10.1016/j.jacc.2017.01.032.

PMID:
28359513

Supplemental Content

Support Center